Evidence map›Paper›PMID 25517170›Full record

ArticleBiophysical journal2014

A GTPase chimera illustrates an uncoupled nucleotide affinity and release rate, providing insight into the activation mechanism.

Amy P Guilfoyle, Chandrika N Deshpande, Josep Font Sadurni, Miriam-Rose Ash, Samuel Tourle, Gerhard Schenk, Megan J Maher, Mika Jormakka

Open access · bronzeAbstract readLetter
In one paragraph

Article in Biophysical journal, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.1field-weighted citation impact, top 47% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 4 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 2 countries.

Amy P GuilfoyleStructural Biology Program, Centenary Institute, Sydney, New South Wales, Australia; Faculty of Medicine, Central Clinical School, University of Sydney, Sydney, New South Wales, Australia.
Chandrika N DeshpandeStructural Biology Program, Centenary Institute, Sydney, New South Wales, Australia; Faculty of Medicine, Central Clinical School, University of Sydney, Sydney, New South Wales, Australia.
Josep Font SadurniStructural Biology Program, Centenary Institute, Sydney, New South Wales, Australia; Faculty of Medicine, Central Clinical School, University of Sydney, Sydney, New South Wales, Australia.
Miriam-Rose AshDepartment of Molecular Biology and Genetics, Aarhus University, Aarhus, Denmark.
Samuel TourleStructural Biology Program, Centenary Institute, Sydney, New South Wales, Australia; Faculty of Medicine, Central Clinical School, University of Sydney, Sydney, New South Wales, Australia.
Gerhard SchenkSchool of Chemistry and Molecular Biosciences, The University of Queensland, St. Lucia, Queensland, Australia.
Megan J MaherLa Trobe Institute for Molecular Science, La Trobe University, Melbourne, Victoria, Australia. Electronic address: m.maher@latrobe.edu.au.
Mika JormakkaStructural Biology Program, Centenary Institute, Sydney, New South Wales, Australia; Faculty of Medicine, Central Clinical School, University of Sydney, Sydney, New South Wales, Australia. Electronic address: m.jormakka@centenary.org.au.
The University of Sydney · AUAarhus University · DKLa Trobe University · AUThe University of Queensland · AU

Funding

NCI NIH HHS Y1-CO-1020NIGMS NIH HHS Y1-GM-1104
6 · The paper itself

Abstract

The release of GDP from GTPases signals the initiation of a GTPase cycle, where the association of GTP triggers conformational changes promoting binding of downstream effector molecules. Studies have implicated the nucleotide-binding G5 loop to be involved in the GDP release mechanism. For example, biophysical studies on both the eukaryotic Gα proteins and the GTPase domain (NFeoB) of prokaryotic FeoB proteins have revealed conformational changes in the G5 loop that accompany nucleotide binding and release. However, it is unclear whether this conformational change in the G5 loop is a prerequisite for GDP release, or, alternatively, the movement is a consequence of release. To gain additional insight into the sequence of events leading to GDP release, we have created a chimeric protein comprised of Escherichia coli NFeoB and the G5 loop from the human Giα1 protein. The protein chimera retains GTPase activity at a similar level to wild-type NFeoB, and structural analyses of the nucleotide-free and GDP-bound proteins show that the G5 loop adopts conformations analogous to that of the human nucleotide-bound Giα1 protein in both states. Interestingly, isothermal titration calorimetry and stopped-flow kinetic analyses reveal uncoupled nucleotide affinity and release rates, supporting a model where G5 loop movement promotes nucleotide release.

Indexed as

Amino Acid SequenceCation Transport ProteinsEscherichia coli ProteinsGTP-Binding Protein alpha Subunits, Gi-GoGuanosine DiphosphateHumansMolecular Sequence DataProtein BindingProtein Structure, TertiaryRecombinant ProteinsCation Transport ProteinsEscherichia coli ProteinsFeoB protein, E coliGTP-Binding Protein alpha Subunits, Gi-GoGuanosine DiphosphateRecombinant Proteins

Identifiers

PMID25517170
PMCPMC4269768
OpenAlexW1965489120

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.